Pioglitazone attenuates progression of aortic valve calcification via down-regulating receptor for advanced glycation end products-Reference-Cited by-同舟云学术

Pioglitazone attenuates progression of aortic valve calcification via down-regulating receptor for advanced glycation end products

Published:2012-10-16 Issue:6 Volume:107 Page:
ISSN:0300-8428
Container-title:Basic Research in Cardiology
language:en
Short-container-title:Basic Res Cardiol

Author:

Li Fei,Cai Zhejun,Chen Fang,Shi Xucong,Zhang Qiao,Chen Si,Shi Jiawei,Wang Dao Wen,Dong Nianguo

Publisher

Springer Science and Business Media LLC

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine,Physiology

Link

http://link.springer.com/content/pdf/10.1007/s00395-012-0306-0.pdf

Reference51 articles.

1. Al-Aly Z, Shao JS, Lai CF, Huang E, Cai J, Behrmann A, Cheng SL, Towler DA (2007) Aortic Msx2-Wnt calcification cascade is regulated by TNF-alpha-dependent signals in diabetic Ldlr−/− mice. Arterioscler Thromb Vasc Biol 27:2589–2596. doi: 10.1161/ATVBAHA.107.153668

2. Basta G, Corciu AI, Vianello A, Del Turco S, Foffa I, Navarra T, Chiappino D, Berti S, Mazzone A (2010) Circulating soluble receptor for advanced glycation end-product levels are decreased in patients with calcific aortic valve stenosis. Atherosclerosis 210:614–618. doi: 10.1016/j.atherosclerosis.2009.12.029

3. Beckmann E, Grau JB, Sainger R, Poggio P, Ferrari G (2010) Insights into the use of biomarkers in calcific aortic valve disease. J Heart Valve Dis 19:441–452

4. Birnbaum Y, Long B, Qian J, Perez-Polo JR, Ye Y (2011) Pioglitazone limits myocardial infarct size, activates Akt, and upregulates cPLA2 and COX-2 in a PPAR-gamma-independent manner. Basic Res Cardiol 106:431–446. doi: 10.1007/s00395-011-0162-3

5. Bonow RO, Carabello BA, Chatterjee K, De Leon AC Jr, Faxon DP, Freed MD, Gaasch WH, Lytle BW, Nishimura RA, O’Gara PT, O’Rourke RA, Otto CM, Shah PM, Shanewise JS (2008) 2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American college of Cardiology/American heart association task force on practice guidelines (writing committee to revise the 1998 guidelines for the management of patients with valvular heart disease): endorsed by the society of cardiovascular anesthesiologists, society for cardiovascular angiography and interventions, and society of thoracic surgeons. Circulation 118:e523–e661. doi: 10.1161/CIRCULATIONAHA.108.190748

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of PPAR-gamma agonists on the calcifying degeneration of cardiovascular grafts;Zeitschrift für Herz-,Thorax- und Gefäßchirurgie;2023-06-06

2. Capsaicin inhibits aortic valvular interstitial cell calcification via the redox-sensitive NFκB/AKT/ERK1/2 pathway;Biochemical Pharmacology;2023-06

3. Aortic stenosis: a review on acquired pathogenesis and ominous combination with diabetes mellitus;The Egyptian Heart Journal;2023-04-07

4. Tanshinone IIA attenuates valvular interstitial cells’ calcification induced by oxidized low density lipoprotein via reducing endoplasmic reticulum stress;Open Medicine;2023-01-01

5. Impact of PPAR-gamma activation on the durability of biological heart valve prostheses in hypercholesterolaemic rats;European Journal of Cardio-Thoracic Surgery;2022-12-02